As we approach the end of the year, it’s time for Engadget to wrap up the successes and failures in tech from the last twelve months. While it might be easier point out the messes made by the likes of crypto, Google’s Stadia cloud gaming platform and, ugh, Twitter, there were some highlights too. These include the eventual arrival of Steam’s handheld gaming PC, all those Wordle options, and some dazzling new views of space. The worst of 2022 centers an awful lot on tech bros, if you hadn’t rolled your eyes at them enough in the preceding years. From the collapse of FTX to the precarious state of Twitter, it’s been a mess. Meanwhile, the likes of Peloton have struggled to hold onto their pandemic user base, and Toyota’s EV efforts haven’t been great. Check out all our hits and our misses of 2022.
– Mat Smith
The Morning After isn’t just a newsletter – it’s also a daily podcast. Get our daily audio briefings, Monday through Friday, by subscribing right here.
The biggest stories you might have missed
Amazon might be making a standalone sports streaming app
No word yet on when the company expects to launch the service.
A report from The Information says that Amazon is working on a new standalone streaming app to declutter Prime Video and better highlight its deals with the NFL, the UK’s Premier League and New York Yankees. The development follows recent comments from Amazon CEO Andy Jassy, who highlighted live sports content as one of the areas where the company plans to continue spending money even as it cuts costs in other areas. The Information says it doesn’t know when Amazon might release the app, nor if the company plans to charge separately for access to Prime Video’s sports content. The outlet also notes Amazon may decide to shelve the app. Amazon did not immediately respond to Engadget’s comment request. Earlier this month, Google reportedly agreed to pay between $2.1 billion and $2.2 billion for the NFL’s Sunday Ticket package.
The Evie is a smart ring designed 'for women'
It can measure heart rate, clinical SpO2, skin temperature variability and more.
Health company Movano has teased its first smart ring, the Evie, designed for health, fitness and cycle tracking. It looks like a rival to Oura's latest smart ring, though the company says it's "designed uniquely for women." It offers many of the health metrics seen on Oura's ring and wearables from Apple and others. It can measure heart rate, blood-oxygen, skin temperature variability, steps, calories, sleep, period and ovulation tracking, and more. Movano plans to provide a closer look next week at CES 2023.
A Stan Lee documentary will hit Disney+ next year
Marvel announced the news on Lee’s 100th birthday.
Yesterday was Marvel legend Stan Lee's 100th birthday and the comic giant marked the occasion by revealing that a documentary about his life will hit Disney+ next year. Lee, who died in 2018, is a critical part of Marvel’s legacy. The many, many characters he’s credited with co-creating include Spider-Man, Iron Man, Black Panther, Ant-Man, X-Men, The Fantastic Four and The Incredible Hulk. Disney has mined its history for several documentary projects for its streaming service. When Disney+ debuted three years ago, it featured a docuseries on the Imagineers, the minds behind its theme parks.
Researchers develop blood test that can reliably detect Alzheimer’s disease
The test could replace lumbar punctures and brain scans.
When doctors need to confirm an Alzheimer's diagnosis, alongside brain scans, it can involve a lumbar puncture – an invasive and painful procedure that’s more commonly known as a spinal tap. The next best tool for diagnosing Alzheimer’s disease is a blood test. While some tests can detect abnormal tau protein counts as a possible indicator of Alzheimer’s disease, they’re less effective at spotting the telltale signs of neurodegeneration. But this week, in the journal Brain, a multinational team of researchers from Sweden, Italy, the UK and US detailed a new antibody-based blood test that can detect brain-derived tau proteins specific to Alzheimer’s disease. Following a study of 600 patients, the team found their test could reliably distinguish the illness from other neurodegenerative diseases.